JFB vs MRNA · rev $30.5M vs rev $145.0M
JFB Construction Holdings Class A Common Stock (JFB) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
JFB Construction Holdings Class A Common Stock (JFB) is a real estate - development company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported JFB revenue for 2025-12-31 was $30.5M. Net income was -$5.3M. Revenue was up 32.3% from 2024-12-31 to 2025-12-31. JFB currently screens at market cap $77.4M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
JFB currently screens at market cap $77.4M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the JFB and MRNA stock pages for the full models.
Not investment advice.